Form 424B3 - Prospectus [Rule 424(b)(3)]:
SEC Accession No. 0001437749-24-036051
Filing Date
2024-11-22
Accepted
2024-11-22 16:12:09
Documents
3

Document Format Files

Seq Description Document Type Size
1 FORM 424B3 clnn20241119_424b3.htm 424B3 256730
2 clenelogo11percent.jpg GRAPHIC 10252
3 pipelineoct202423pct.jpg GRAPHIC 100584
  Complete submission text file 0001437749-24-036051.txt   410740
Mailing Address 6550 SOUTH MILLROCK DRIVE, SUITE G50 SALT LAKE CITY UT 84121
Business Address 6550 SOUTH MILLROCK DRIVE, SUITE G50 SALT LAKE CITY UT 84121 801-676-9695
Clene Inc. (Filer) CIK: 0001822791 (see all company filings)

EIN.: 852828339 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B3 | Act: 33 | File No.: 333-283204 | Film No.: 241489868
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)